An initial or temporary fluctuation in CA 125 tumor marker levels can occasionally occur due to post-treatment inflammation, tissue healing, or benign cellular irritation immediately following chemotherapy. However, a persistent or rising trend in CA 125 levels typically warrants close clinical evaluation by an oncologist, as it may signal a lack of treatment response or indicate potential disease recurrence requiring further diagnostic imaging.